1. The company reported $87 million in net income for the fourth quarter of 2014, down from $108 million in the fourth quarter of 2013. The decline in revenue was due to an increase in operating expenses and one-time charges, according to the report.
2. Boston Scientific reported charges of $216 million, post-tax charges for the quarter, up from $182 million in charges for the prior year period.
3. Though profit was down, the company’s sales inched upward 3 percent from $1.89 billion in the fourth quarter of 2013 to $1.84 million in the prior year period.
4. The company’s reported flat sales for its endoscopy service line.
More articles on gastroenterology:
Preparing for potential GI payment cuts: 3 quick tips
Kaiser Permanente Fresno names Dr. Smita Rouillard hospital physician leader
GI physician leader to know: Dr. Geoffrey Braden of G.I. Specialists
